Yes. Uppsala University is one of the leading medical research institutes in the world and a European Centre of Excellence for the treatment of neuroendocrine cancer.

Professor Kjell Öberg, the clinician now running the trial, is a former President of the European Neuroendocrine Tumour Society (ENETS).

Pre-clinical results have been published in peer-reviewed journals, and the clinical trial now underway has had to get over all the usual, rigorous ethical and regulatory hurdles, which ensure that the scientific research and trial design are of good quality.